Literature DB >> 24158636

[Stereotactic body radiotherapy for the treatment of hepatocellular cancer. Pooled analysis of two phase I/II trials].

D Habermehl1, S E Combs.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24158636     DOI： 10.1007/s00066-013-0449-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  12 in total

Review 1.  Radiation therapy for hepatocellular carcinoma.

Authors:  Mary Feng; Edgar Ben-Josef
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

2.  Stereotactic body radiotherapy for primary hepatocellular carcinoma.

Authors:  David L Andolino; Cynthia S Johnson; Mary Maluccio; Paul Kwo; A Joseph Tector; Jennifer Zook; Peter A S Johnstone; Higinia R Cardenes
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-07       Impact factor: 7.038

3.  Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma.

Authors:  Alexis Bujold; Christine A Massey; John J Kim; James Brierley; Charles Cho; Rebecca K S Wong; Rob E Dinniwell; Zahra Kassam; Jolie Ringash; Bernard Cummings; Jenna Sykes; Morris Sherman; Jennifer J Knox; Laura A Dawson
Journal:  J Clin Oncol       Date:  2013-04-01       Impact factor: 44.544

4.  Individualized image guided iso-NTCP based liver cancer SBRT.

Authors:  Laura A Dawson; Cynthia Eccles; Tim Craig
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

5.  Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.

Authors:  Alejandra Méndez Romero; Wouter Wunderink; Shahid M Hussain; Jacco A De Pooter; Ben J M Heijmen; Peter C J M Nowak; Joost J Nuyttens; Rene P Brandwijk; Cees Verhoef; Jan N M Ijzermans; Peter C Levendag
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

6.  Radiation treatment outcomes for unresectable hepatocellular carcinoma.

Authors:  Heath D Skinner; Hadley J Sharp; Ahmed O Kaseb; Milind M Javle; Jean Nicolas Vauthey; Eddie K Abdalla; Marc E Delclos; Prajnan Das; Christopher H Crane; Sunil Krishnan
Journal:  Acta Oncol       Date:  2011-07-27       Impact factor: 4.089

7.  Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance.

Authors:  Shi-Xiong Liang; Xiao-Dong Zhu; Zhi-Yong Xu; Ji Zhu; Jian-Dong Zhao; Hai-Jie Lu; Yun-Li Yang; Long Chen; An-Yu Wang; Xiao-Long Fu; Guo-Liang Jiang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-06-01       Impact factor: 7.038

8.  Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma.

Authors:  Zhi-Yong Xu; Shi-Xiong Liang; Ji Zhu; Xiao-Dong Zhu; Jian-Dong Zhao; Hai-Jie Lu; Yun-Li Yang; Long Chen; An-Yu Wang; Xiao-Long Fu; Guo-Liang Jiang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-03-20       Impact factor: 7.038

9.  Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors:  Regina V Tse; Maria Hawkins; Gina Lockwood; John J Kim; Bernard Cummings; Jennifer Knox; Morris Sherman; Laura A Dawson
Journal:  J Clin Oncol       Date:  2008-01-02       Impact factor: 44.544

10.  Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma - feasibility and clinical response.

Authors:  Daniel Habermehl; Jürgen Debus; Tom Ganten; Maria-Katharina Ganten; Julia Bauer; Ingo C Brecht; Stephan Brons; Thomas Haberer; Martin Haertig; Oliver Jäkel; Katia Parodi; Thomas Welzel; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2013-03-13       Impact factor: 3.481
View more
  2 in total

Review 1.  Individualized radiotherapy (iRT) concepts for locally advanced pancreatic cancer (LAPC): indications and prognostic factors.

Authors:  Stephanie E Combs
Journal:  Langenbecks Arch Surg       Date:  2015-07-03       Impact factor: 3.445

2.  Evaluation of inter- and intrafractional motion of liver tumors using interstitial markers and implantable electromagnetic radiotransmitters in the context of image-guided radiotherapy (IGRT) - the ESMERALDA trial.

Authors:  Daniel Habermehl; Patrick Naumann; Rolf Bendl; Uwe Oelfke; Simeon Nill; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2015-07-14       Impact factor: 3.481
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.